Literature DB >> 8309485

Hyperglycemia as a paraneoplastic endocrinopathy in renal cell carcinoma: a case report and review of the literature.

B A Jobe1, M H Bierman, F J Mezzacappa.   

Abstract

A case of renal cell carcinoma presenting with severe hyperglycemia, ketoacidosis, and hyperosmolar coma is described. Hyperglycemia was difficult to control but improved dramatically after nephrectomy and required no further insulin therapy. Hyperglycemia as a paraneoplastic endocrinopathy in renal cell carcinoma is suggested.

Entities:  

Mesh：

Year:  1993        PMID： 8309485

Source DB:  PubMed          Journal:  Nebr Med J        ISSN： 0091-6730


  4 in total

1.  Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.

Authors:  Daniel M Moreira; Boris Gershman; Christine M Lohse; Stephen A Boorjian; John C Cheville; Bradley C Leibovich; Robert Houston Thompson
Journal:  World J Urol       Date:  2016-02-25       Impact factor: 4.226

2.  Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.

Authors:  Ryan Sun; Rodney H Breau; Ranjeeta Mallick; Simon Tanguay; Frederic Pouliot; Anil Kapoor; Luke T Lavallée; Antonio Finelli; Alan I So; Ricardo A Rendon; Adrian S Fairey; Jean-Baptiste Lattouf; Jun Kawakami; Bimal Bhindi; Naveen S Basappa; Lori A Wood; Georg A Bjarnason; Daniel Y C Heng; Rahul K Bansal
Journal:  Can Urol Assoc J       Date:  2021-04       Impact factor: 1.862

3.  New onset hyperglycemia attributed to renal cell carcinoma.

Authors:  Jonathan Gapp; Muhammad Fazeel Anwar; Jai Parekh; Timothy Griffin
Journal:  Intractable Rare Dis Res       Date:  2018-05

4.  Glucagon-producing mucinous tubular and spindle cell variant of renal cell carcinoma with paraneoplastic diabetes: Case report and review of literature.

Authors:  Ashish Khanna; Sharwan Kumar Singh; Ritambara Nada
Journal:  Indian J Urol       Date:  2021-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.